| LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin. | LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin.
Yu Q, Guo K, Yang Y, Liu H, Huang Y, Li W. | 02/15/2024 |
| A review on the role of ADAMTS9-AS2 in different disorders. | A review on the role of ADAMTS9-AS2 in different disorders.
Ghafouri-Fard S, Askari A, Hussen BM, Baniahmad A, Taheri M, Mokhtari M. | 03/14/2023 |
| ADAMTS9-AS2 Promotes Angiogenesis of Brain Microvascular Endothelial Cells Through Regulating miR-185-5p/IGFBP-2 Axis in Ischemic Stroke. | ADAMTS9-AS2 Promotes Angiogenesis of Brain Microvascular Endothelial Cells Through Regulating miR-185-5p/IGFBP-2 Axis in Ischemic Stroke.
Feng N, Wang Z, Wu Y, Zheng H, Jiang X, Wang Z, Qu F, Zhang Z. | 04/30/2022 |
| The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population. | The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population.
Abdul-Maksoud RS, Rashad NM, Elsayed WSH, Elsayed RS, Sherif MM, Abbas A, El Shabrawy M. | 04/2/2022 |
| Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p. | Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
Guo Q, Ni P, Dai Y, Hu J, Yao Y. | 11/13/2021 |
| ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis. | ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.
Xu W, Wang B, Cai Y, Chen J, Lv X, Guo C, Yuan C. | 10/30/2021 |
| ADAMTS9-AS2 and CADM2 expression and association with the prognosis in esophageal squamous cell carcinoma. | ADAMTS9-AS2 and CADM2 expression and association with the prognosis in esophageal squamous cell carcinoma.
Shen FF, Zhang F, Yang HJ, Li JK, Su JF, Yu PT, Zhou FY, Che GW. | 10/23/2021 |
| Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway. | Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
Zhou S, Zhu Y, Li Z, Zhu Y, He Z, Zhang C., Free PMC Article | 09/25/2021 |
| LncRNA ADAMTS9-AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP. | LncRNA ADAMTS9-AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP.
Wang F, Tang C, Xu D, Tang Y, Jiang Y, Gao X, Xu J., Free PMC Article | 05/1/2021 |
| LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis. | LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N, Jiang T, Wang C, Xie S, Xing Y, Piao D, Zhang T, Zhu Y., Free PMC Article | 02/27/2021 |
| LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis. | LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL, Xing L, Wang L, Song WT, Li DB, Wang Y, Gu YW, Liu MM, Ni WJ, Zhang P, Ma X, Zhang X, Yao J, Chen Y, An RH., Free PMC Article | 08/22/2020 |
| Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer. | Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.
Pan H, Pan J, Song S, Ji L, Lv H, Yang Z., Free PMC Article | 08/15/2020 |
| Overexpressed ADAMTS9-AS2 aids in the suppression of esophageal cancer development, which is achieved via inducing CDH3 promoter methylation. | Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.
Liu D, Wu K, Yang Y, Zhu D, Zhang C, Zhao S. | 04/18/2020 |
| high LINC00460 expression and low ADAMTS9-AS1 expression in bladder cancer as compared with normal bladder tissues; Differential expression results of ADAMTS9-AS1 suggests it may be correlated with a worse prognosis and a shorter survival time | Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
Lin YZ, Wu YP, Ke ZB, Cai H, Chen DN, Chen SH, Li XD, Lin TT, Huang JB, Zheng QS, Xue XY, Xu N, Wei Y., Free PMC Article | 04/18/2020 |
| ADAMTS9-AS2 promotes migration and invasion in SACC by competing with miR-143-3p. This sheds a new insight into the regulation mechanism of ADAMTS9-AS2, and it provides a possible application for the SACC treatment. | Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
Xie S, Yu X, Li Y, Ma H, Fan S, Chen W, Pan G, Wang W, Zhang H, Li J, Lin Z., Free PMC Article | 10/5/2019 |
| Our results demonstrate an explicit oncogenic role of ADAMTS9-AS2 in tongue squamous cell carcinoma tumorigenesis. | LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
Li Y, Wan Q, Wang W, Mai L, Sha L, Mashrah M, Lin Z, Pan C. | 09/7/2019 |
| ADAMTS9-AS2 overexpression in colorectal cancer cells inhibited cell proliferation, migration, and invasion, while suppression of ADAMTS9-AS2 showed opposite effects | [Overexpression of the long non-coding RNA ADAMTS9-AS2 suppresses colorectal cancer proliferation and metastasis].
Bu X, Qin A, Luo Z, Hu Y. | 08/24/2019 |
| Low ADAMTS9-AS2 expression is associated with progression of lung cancer. | Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C, Yang Z, Deng Z, Zhou Y, Gong Q, Zhao R, Chen T. | 06/1/2019 |
| lncRNA ADAMTS9-AS2 decreased OC progression by regulating miR-182-5p/FOXF2 axis | LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A, Jin C, Li H, Qin Q, Li L. | 01/26/2019 |